Immucor makes sure you can feel safe about getting a blood transfusion. The company develops, makes, and sells manual and automated analysis equipment used by blood banks, hospitals, and clinical laboratories to test blood prior to transfusions. Its traditional reagents are used to manually test samples for blood type, group matching, and foreign substance detection, while its Galileo, Galileo Echo, and Galileo NEO automated instrumentation systems use traditional and proprietary Capture reagents to perform multiple blood tests at one time. The company sells its products primarily in North America, Western Europe, and Japan. Founded in 1982, Immucor is owned by TPG Capital.